Catalyst
Slingshot members are tracking this event:
Phase 2b topline data of Emricasan fo Liver fibrosis post orthotopic liver trasplant due to Hepatitis C virus infection (HCV-POLT) due 1H 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CNAT | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 04, 2018
Occurred Source:
http://ir.conatuspharma.com/news-releases/news-release-details/conatus-pharmaceuticals-announces-top-line-results-phase-2b-polt
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2b Topline Data, Emricasan, Liver Fibrosis, Post Orthotopic Liver Transplant, Hepatitis C
